The global consciousness regarding public health has been irrevocably altered. In the wake of recent pandemics and with the persistent threat of novel pathogens, the biosafety and infection control sector has transformed from a niche healthcare segment into a critical, high-growth global industry. For investors, this represents a foundational shift, creating a market poised for…